[Tricuspid atresia. Clinical course in 120 children]

A A Rosado-Buzzo1, H Santamaría-Díaz, M Gómez-Gómez

  • 1Hospital de Cardiología y Neumología Luis Méndez, Centro Médico Nacional del Instituto Mexicano del Seguro Social, D.F.

Archivos Del Instituto De Cardiologia De Mexico
|September 1, 1987
PubMed

Insights

This study analyzes 120 children with tricuspid atresia (TA), finding hypoxic spells common. Management strategies and outcomes are detailed, offering insights for pediatric cardiology.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Echocardiography

Context:

  • Tricuspid atresia (TA) is a critical congenital heart defect.
  • Early diagnosis and management are crucial for infant survival.
  • Understanding clinical presentation aids in timely intervention.

Purpose:

  • To describe the clinical course of 120 children with tricuspid atresia.
  • To analyze diagnostic findings, including chest X-ray and ECG.
  • To review management strategies and outcomes in pediatric TA patients.

Summary:

  • The study reviewed 120 pediatric tricuspid atresia (TA) cases.
  • Common presentations included hypoxic spells (89%) and cardiomegaly (85%).
  • Management involved medical therapy, systemic-pulmonary anastomosis (63), and Fontan procedures (13), with 21 deaths.

Impact:

  • Provides a comprehensive overview of tricuspid atresia in a pediatric cohort.
  • Highlights key diagnostic features and common clinical presentations.
  • Offers data for refining management protocols and improving outcomes for congenital heart disease.

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...